Novo Nordisk strikes deal worth up to $1.1 billion to expand cardio business
Denmark's Novo Nordisk said on Monday it had agreed to buy Cardior Pharmaceuticals for up to 1.03 billion euros ($1.1 billion) to strengthen its cardiovascular pipeline.
Pharmaceuticals asian news
AstraZeneca to withdraw Covid vaccine worldwide, citing a drop in demand
Pharmaceutical giant AstraZeneca on Wednesday said it planned to withdraw its Covid-19 vaccine as demand for it has declined.
Generative AI is speeding up human-like robot development. What that means for jobs
BEIJING — ChatGPT-like artificial intelligence is speeding up research and bringing humanoid robots closer to reality in China, home to many of the world's factories.
Wegovy maker Novo Nordisk extends losses following first-quarter results
Shares of Danish pharmaceutical giant Novo Nordisk slid 2.5% on Friday, extending a 2.7% loss on Thursday as analysts pored over the details of the firm's first-quarter results and monitored a potential rival weight loss treatment.
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
Novo Nordisk, which became the most valuable company in Europe last year due to the blockbuster success of its weight loss drugs, on Thursday beat first-quarter profit expectations as demand for those medications boomed.
Europe stocks fall as earnings roll in; ING up 5%; traders react to Fed decision
This is CNBC's live blog covering European markets.
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
Eli Lilly on Tuesday reported first-quarter adjusted profit that topped Wall Street's expectations and hiked its full-year guidance on strong sales of its blockbuster diabetes drug Mounjaro and newly launched weight loss treatment Zepbound.
Swiss pharma giant Roche's first-quarter sales edge higher as its emerges from post-Covid-19 slump
Swiss pharmaceutical company Roche on Wednesday reported a modest uptick in first-quarter sales, even as waning demand for its Covid-19 products continued to weigh on the company.
Singapore non oil domestic exports plunge 20.7%, misses expectations by a huge margin
Singapore's non-oil domestic exports plunged 20.7% in March from a year ago, a sharp decline from the revised 0.2% fall in February.